Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Parathyroid Neoplasms 3Hyperparathyroidism, Primary 3Hyperparathyroidism 3Neoplasm Metastasis 2Prostatic Neoplasms 1Osteoporosis 1Hyperparathyroidism, Secondary 1Hypercalcemia 1Chronic Kidney Disease-Mineral and Bone Disorder 1

Interventions

Zoledronic Acid 16Risedronic Acid 9Vitamin D 8Calcium 8Letrozole 6Cholecalciferol 5Calcium Carbonate 5Alendronate 5Denosumab 4Absorptiometry, Photon 4Calcium Gluconate 3parathyroid hormone-related peptide (1-36) 2bicalutamide 2Resistance Training 2Progesterone 2Nutrition Assessment 2Kyphoplasty 2Hormone Replacement Therapy 2Goserelin 2Estradiol 2Calcium Citrate 2xian ling gu bao 1romosozumab 1X-Rays 1Toremifene 1Testosterone 1Technetium 1Spectrum Analysis 1Raloxifene Hydrochloride 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Osteoporosis × Cinacalcet × Clear all
NCT04637360 2020-11-19

Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment

Min-Sheng General Hospital

Phase NA Completed
40 enrolled
Head & Neck

Hyperparathyroidism, Neoplasm Metastasis, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡